References
- J. Moncrieff, R. E. Cooper, T. Stockmann, S. Amendola, M. P. Hengartner and M. A. Horowitz, The serotonin theory of depression: A systematic umbrella review of the evidence, Mol. Psychiatry 28(8) (2023) 3243–3256; https://doi.org/10.1038/s41380-022-01661-0
- G. Ślifirski, M. Król and J. Turło, 5-HT receptors and the development of new antidepressants, Int. J. Mol. Sci. 22(16) (2021) Article ID 9015 (31 pages); https://doi.org/10.3390/ijms22169015
- C. Wang, N. Zhang, Y. Shao, T. Li, M. Zhang, M. Gao, Y. Liang, Y. Wang, T. Xue, Y. Shi, H. Chen and C. Cao, Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy, Cell 188(25) (2025) 7222–7237; https://doi.org/10.1016/j.cell.2025.10.022
- Y. Jiang, Y. Qu, Z. Du, M. Ou, Y. Shen, Q. Zhou, L. Tian and H. Zhu, Exploring adverse events of vilazodone: Evidence from the FAERS database, BMC Psychiatry 24(1) (2024) Article ID 371 (9 pages); https://doi.org/10.1186/s12888-024-05813-0
- N. Zareifopoulos and I. Dylja, Efficacy and tolerability of vilazodone for the acute treatment of generalized anxiety disorder: A meta-analysis, Asian J. Psychiatr. 26 (2017) 115–122; https://doi.org/10.1016/j.ajp.2017.01.016
- K. L. Szuhany and N. M. Simon, Anxiety disorders: A review, JAMA 328(24) (2022) 2431–2445; https://doi.org/10.1001/jama.2022.22744
- B. W. Penninx, D. S. Pine, E. A. Holmes and A. Reif, Anxiety disorders, Lancet 397(10277) (2021) 914–927; https://doi.org/10.1016/s0140-6736(21)00359-7
- A. Fernández-Teruel and A. Tobeña, Revisiting the role of anxiety in the initial acquisition of two--way active avoidance: Pharmacological, behavioural and neuroanatomical convergence, Neurosci. Biobehav. Rev. 118 (2020) 739–758; https://doi.org/10.1016/j.neubiorev.2020.08.014
- C. B. Klune, C. M. Goodpaster, M. W. Gongwer, C. J. Gabriel, J. An, R. Chen, N. S. Jones, O. H. Williams, M. Shari, M. Ramirez, A. Hacking, T. Andrade, L. A. Schwarz and L. A. DeNardo, Developmentally distinct architectures in top-down pathways controlling threat avoidance, Nat. Neurosci. 28(4) (2025) 823–835; https://doi.org/10.1038/s41593-025-01890-w
- H. Esaki, Y. Sasaki, N. Nishitani, H. Kamada, S. Mukai, Y. Ohshima, S. Nakada, X. Ni, S. Deyama and K. Kaneda, Role of 5-HT1A receptors in the basolateral amygdala on 3,4-methylenedioxymeth-amphetamine-induced prosocial effects in mice, Eur. J. Pharmacol. 946 (2023) Article ID 175653 (7 pages); https://doi.org/10.1016/j.ejphar.2023.175653
- Y.-F. Jiang, J. Liu, J. Yang, Y. Guo, W. Hu, J. Zhang, X.-M. La, W. Xie, H.-S. Wang and L. Zhang, Involvement of the dorsal hippocampus 5-HT1A receptors in the regulation of depressive-like behaviors in hemiparkinsonian rats, Neuropsychobiology 79(3) (2020) 198–207; https://doi.org/10.1159/000505212
- L. Wang, Z. Zhu, W. Hou, X. Zhang, Z. He, W. Yuan, Y. Yang, S. Zhang, R. Jia and F. Tai, Serotonin signaling trough prelimbic 5-HT1A receptors modulates csds-induced behavioral changes in adult female voles, Int. J. Neuropsychopharmacol. 22(3) (2019) 208–220; https://doi.org/10.1093/ijnp/pyy093
- C. M. de Arruda, D. L. Doneda, V. V. de Oliveira, R. A. L. da Silva, Y. A. V. de Matos, I. L. Fernandes, C. A. H. Rohden, G. G. Viola, F. Rios-Santos, E. de Lima, Z. da Silva Buss and S. Vandresen-Filho, Involvement of kynurenine pathway and N-methyl-d-aspartate receptors in the antidepressant-like effect of vilazodone in the tail suspension test in mice, Pharmacol. Biochem. Behav. 218 (2022) Article ID 173433 (7 pages); https://doi.org/10.1016/j.pbb.2022.173433
- E. B. Fraga-Junior, I. L. Fernandes, C. A. H. Rohden, D. L. Doneda, H. N. Ynoue, F. Rios-Santos, E. Lima, Z. S. Buss and S. Vandresen-Filho, Attenuation of the levels of pro-inflammatory cytokines prevents depressive-like behavior during ethanol withdrawal in mice, Brain. Res. Bull. 191 (2022) 9–19; https://doi.org/10.1016/j.brainresbull.2022.10.014
- M. L. Seibenhener and M. C. Wooten, Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice, J. Vis. Exp. (96) (2015) e52434 (9 pages); https://doi.org/10.3791/52434
- T. Macheda, H. C. Snider, J. B. Watson, K. N. Roberts and A. D. Bachstetter, An active avoidance behavioral paradigm for use in a mild closed head model of traumatic brain injury in mice, J. Neurosci. Methods 343 (2020) Article ID 108831 (9 pages); https://doi.org/10.1016/j.jneumeth.2020.108831
- M. Sakaue, Y. Ago, C. Sowa, Y. Koyama, A. Baba and T. Matsuda, The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze, Eur. J. Pharmacol. 458(1–2) (2003) 141–144; https://doi.org/10.1016/s0014-2999(02)02786-3
- K. C. Klemenhagen, J. A. Gordon, D. J. David, R. Hen and C. T. Gross, Increased fear response to contextual cues in mice lacking the 5-HT1A receptor, Neuropsychopharmacology 31(1) (2006) 101–111; https://doi.org/10.1038/sj.npp.1300774
- P. Simon, R. Dupuis and J. Costentin, Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions, Behav. Brain. Res. 61(1) (1994) 59–64; https://doi.org/10.1016/0166-4328(94)90008-6
- L. Prut and C. Belzung, The open field as a paradigm to measure the effects of drugs on anxiety--like behaviors: A review, Eur. J. Pharmacol. 463(1–3) (2003) 3–33; https://doi.org/10.1016/s0014-2999(03)01272-x
- M. L. Kisipan, R. O. Ojoo, T. I. Kanui and K. S. P. Abelson, Bodyweight, locomotion, and behavioral responses of the naked mole rat (Heterocephalus glaber) to lipopolysaccharide administration, J. Comp. Physiol. A 208(4) (2022) 493–504; https://doi.org/10.1007/s00359-022-01557-y
- R. A. El-Kadi, N. F. AbdelKader, H. F. Zaki and A. S. Kamel, Vilazodone alleviates neurogenesis--induced anxiety in the chronic unpredictable mild stress female rat model: Role of Wnt/β-catenin signaling, Mol. Neurobiol. 61(11) (2024) 9060–9077; https://doi.org/10.1007/s12035-024-04142-3
- A. Spröwitz, J. Bock and K. Braun, Sex-specific positive and negative consequences of avoidance training during childhood on adult active avoidance learning in mice, Front. Behav. Neurosci. 7 (2013) Article ID 143 (11 pages); https://doi.org/10.3389/fnbeh.2013.00143
- R. Ravenelle, J. Lee, C. Fernandes-Henriques, J. Liu, A. K. Friedman, E. Likhtik and N. S. Burghardt, Serotonergic modulation of the BNST-CeA pathway reveals sex differences in fear learning, Nat. Neurosci. 28(9) (2025) 1897–1909; https://doi.org/10.1038/s41593-025-02025-x
- T. J. Philippe, L. Bao, M. E. Koblanski and V. Viau, Sex differences in serotonin 5-HT1A receptor responses to repeated restraint stress in adult male and female rats, Int. J. Neuropsychopharmacol. 25(10) (2022) 863–876; https://doi.org/10.1093/ijnp/pyac046
- E. G. Jacobs, L. M. Holsen, K. Lancaster, N. Makris, S. Whitfield-Gabrieli, A. Remington, B. Weiss, S. Buka, A. Klibanski and J. M. Goldstein, 17β-estradiol differentially regulates stress circuitry activity in healthy and depressed women, Neuropsychopharmacology 40(3) (2015) 566–576; https://doi.org/10.1038/npp.2014.203
- S. Gupta, M. Wang, Y. Azuma and N. A. Muma, Regulation of serotonin 1A receptor SUMOylation by SENP2 and PIASxα, Int. J. Mol. Sci. 22(24) (2021) Article ID 13176 (14 pages); https://doi.org/10.3390/ijms222413176
- J. Wendt, A. Löw, M. Weymar, M. Lotze and A. O. Hamm, Active avoidance and attentive freezing in the face of approaching threat, Neuroimage 158 (2017) 196–204; https://doi.org/10.1016/j.neuroimage.2017.06.054
- F. H. Klaassen, L. Held, B. Figner, J. X. O’Reilly, F. Klumpers, L. D. de Voogd and K. Roelofs, Defensive freezing and its relation to approach-avoidance decision-making under threat, Sci. Rep. 11(1) (2021) Article ID 12030 (12 pages); https://doi.org/10.1038/s41598-021-90968-z
- E. T. Rolls, Emotion, motivation, decision-making, the orbitofrontal cortex, anterior cingulate cortex, and the amygdala, Brain Struct. Funct. 228(5) (2023) 1201–1257; https://doi.org/10.1007/s00429-023-02644-9
- Y.-H. Chen, J.-L. Wu, N.-Y. Hu, J.-P. Zhuang, W.-P. Li, S.-R. Zhang, X.-W. Li, J.-M. Yang and T.-M. Gao, Distinct projections from the infralimbic cortex exert opposing effects in modulating anxiety and fear, J. Clin. Invest. 131(14) (2021) e145692 (17 pages); https://doi.org/10.1172/jci145692
- V. Orgeta, P. Leung, R. Del-Pino-Casado, A. Qazi, M. Orrell, A. E. Spector and A. M. Methley, Psychological treatments for depression and anxiety in dementia and mild cognitive impairment, Cochrane Database Syst. Rev. 4(4) (2022) Cd009125 (156 pages); https://doi.org/10.1002/14651858.CD009125.pub3
- J. R. Strawn, J. A. Mills, V. Suresh, T. S. Peris, J. T. Walkup and P. E. Croarkin, Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety, J. Affect. Disord. 298(Part A) (2022) 292–300; https://doi.org/10.1016/j.jad.2021.10.047
- R. Adamec, G. D. Bartoszyk and P. Burton, Effects of systemic injections of vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats, Eur. J. Pharmacol. 504(1–2) (2004) 65–77; https://doi.org/10.1016/j.ejphar.2004.09.009